ZFYVE16 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.147600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.144600E-01
Normal-vs-Stage2
2.985600E-01
Normal-vs-Stage3
4.180400E-02
Normal-vs-Stage4
8.341000E-01
Stage1-vs-Stage2
6.078400E-01
Stage1-vs-Stage3
9.080200E-02
Stage1-vs-Stage4
6.844000E-01
Stage2-vs-Stage3
1.371040E-01
Stage2-vs-Stage4
3.663400E-01
Stage3-vs-Stage4
8.286200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.096000E-01
Normal-vs-AfricanAmerican
4.687400E-01
Normal-vs-Asian
2.704400E-01
Caucasian-vs-AfricanAmerican
8.037000E-01
Caucasian-vs-Asian
4.235800E-01
AfricanAmerican-vs-Asian
5.409600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.895800E-01
Normal-vs-Female
3.700400E-01
Male-vs-Female
4.487600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.465400E-01
Normal-vs-Age(41-60Yrs)
6.351200E-01
Normal-vs-Age(61-80Yrs)
2.032600E-01
Normal-vs-Age(81-100Yrs)
2.646800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.038400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.751200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.069400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.301540E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.422600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.091770E-01
Normal-vs-Daily Drinker
2.343600E-01
Normal-vs-Weekly Drinker
1.594360E-01
Normal-vs-Occasional Drinker
4.188600E-01
Normal-vs-Social Drinker
6.619200E-01
Non Drinker-vs-Daily Drinker
7.279600E-01
Non Drinker-vs-Weekly Drinker
9.820600E-01
Non Drinker-vs-Occasional Drinker
1.512200E-01
Non Drinker-vs-Social Drinker
6.917900E-02
Daily Drinker-vs-Weekly Drinker
8.009000E-01
Daily Drinker-vs-Occasional Drinker
3.530200E-01
Daily Drinker-vs-Social Drinker
1.962360E-01
Weekly Drinker-vs-Occasional Drinker
2.562000E-01
Weekly Drinker-vs-Social Drinker
1.533830E-01
Occasional Drinker-vs-Social Drinker
6.287000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.974200E-02
Normal-vs-Grade 2
4.717100E-03
Normal-vs-Grade 3
4.161400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.354400E-01
Grade 1-vs-Grade 3
7.777600E-01
Grade 1-vs-Grade 4
3.974200E-02
Grade 2-vs-Grade 3
7.672400E-01
Grade 2-vs-Grade 4
4.717100E-03
Grade 3-vs-Grade 4
4.161400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.650560E-01
Normal-vs-NonDiabetic
2.525200E-01
Diabetic-vs-NonDiabetic
5.497600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.191610E-01
Normal-vs-NoPancreatitis
2.421600E-01
Pancreatitis-vs-NoPancreatitis
3.473000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.938200E-01
Normal-vs-N1
2.947000E-01
N0-vs-N1
9.574800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.457410E-01
Normal-vs-TP53-NonMutant
4.212600E-01
TP53-Mutant-vs-TP53-NonMutant
1.170030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
